The first six months of fiscal year 2017/18 were successful for the ZEISS Group
The first six months of fiscal year 2017/18 (ended 31 March 2018) were successful for the ZEISS Group and saw its revenue rise by 9% to EUR 2.773 billion (1st six months of 2016/17: EUR 2.550 billion), and as much as 13% after adjustments for currency effects. At EUR 380 million, the earnings before interest and tax (EBIT) were high despite clearly negative currency effects compared to the previous year (EUR 384 million). The EBIT margin is at 14%. Incoming orders hit EUR 2.839 billion (1st six months of 2016/17: EUR 2.743 billion).
“It is our business in the high-tech fields of semiconductor manufacturing technology, industrial metrology and medical technology in particular that are enabling our growth and helping further advance the ZEISS Group,” said Prof. Dr. Michael Kaschke, President and CEO of ZEISS. “We are benefitting once again from our balanced and future-oriented portfolio and our broad global footprint.”
In the first half of fiscal year, the segments have been developing according to different dynamics. Particular growth drivers in the Research & Quality Technology segment are still the automotive industry and the great demand for Smart Production solutions. This contrasts with a weaker development in the microscopy business during the first half of the fiscal year. The Medical Technology segment is experiencing strong growth as it is able to gain market share on the hotly contested healthcare market thanks to its many innovative products. In the Vision Car...